Aarti Pharmalabs Limited (AARTIPHARM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2095
First IPO Date
January 30, 2023
| Name | Title | Pay | Year Born |
| Narendra Jagannath Salvi | MD & Director | 19.39M | 1964 |
| Hetal Gogri Gala | Vice Chairperson & MD | 103.2M | 1975 |
| Naidu | Head of Operations & Manufacturing, CDMO & CMO | 0 | N/A |
| Jeevan Bhargav Mondkar | Company Secretary & Compliance Officer | 0 | N/A |
| Sudhakar Shetty | Senior General Manager of HR & Admin | 0 | N/A |
| Rakeshwar Bandichhor | Chief Scientific Officer R&D | 0 | N/A |
| Jasmin Mehta | Head of Business Development & Direct Procurement | 0 | N/A |
| S. Patravale | President of R&D | 0 | N/A |
| Piyush Lakhani | Chief Financial Officer | 0 | N/A |
| Shrihari S. Mane | Chief Technology Officer | 0 | N/A |
Aarti Pharmalabs Limited, headquartered in Mumbai, India, is engaged in the manufacturing and commercialization of a diverse range of pharmaceutical substances across India. Its offerings encompass active pharmaceutical ingredients (APIs), pharmaceutical intermediates, new chemical entities, and xanthine derivatives. The firm, which commenced operations in 2019, was formerly known as Aarti Organics Limited.